Established Semaglutide stacks
GLP-1 + Recovery
Goal: Mitigate GI discomfort during titration in research models
Researchers have explored BPC-157 alongside GLP-1 agonists for gut-tolerance work. Not a clinical recommendation.
How to think about stacking
- Mechanism diversity beats redundancy. Pairing compounds that hit different pathways usually outperforms stacking two compounds with similar mechanisms.
- Track one variable at a time. Starting two peptides simultaneously makes it impossible to attribute effects. Research protocols typically introduce stacks sequentially.
- Side-effect interactions. Some peptides compound each other's side effects (e.g., GLP-1 agonists with other GI-active compounds). Review side-effect profiles before stacking.